Postprandial gallbladder motility and plasma cholecystokinin at regular time intervals after injection of octreotide in acromegalics on long-term treatment-Reference-Cited by-同舟云学术

Postprandial gallbladder motility and plasma cholecystokinin at regular time intervals after injection of octreotide in acromegalics on long-term treatment

Published:1992-11 Issue:11 Volume:37 Page:1685-1690
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Digest Dis Sci

Author:

Hopman W. P. M.,Van Liessum P. A.,Pieters G. F. F. M.,Jansen J. B. M. J.,Lamers C. B. H. W.,Smals A. G. H.,Rosenbusch G.,Kloppenborg P. W. C.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/BF01299859.pdf

Reference33 articles.

1. Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J: SMS 201-995: A very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci 31:1133?1140, 1982

2. Gordon P, Comi RJ, Maton PN, Go VLW: Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumours of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Ann Intern Med 110:35?50, 1989

3. Pieters GFFM, Van Liessum PA, Smals AGH, Van Gennep JA, Benraad TJ, Kloppenborg PWC: Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses. Acta Endocrinol (Copenh) 116(suppl 286):9?18, 1987

4. Hopman WPM, Wolberink RGJ, Lamers CBHW, Van Tongeren JHM: Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995. Ann Surg 207:155?159, 1988

5. Ho KY, Weissberger AJ, Marbach P, Lazarus L: Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Ann Intern Med 36:108?124, 1990

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applied hepatobiliary scintigraphy in chronic gallbladder diseases;Applied Radiology;2016-09-01

2. Somatostatin receptor subtypes 2 and 5 mediate inhibition of egg yolk-induced gall bladder emptying in mice;Neurogastroenterology & Motility;2010-02

3. Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR;Alimentary Pharmacology & Therapeutics;2001-02-05

4. Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly;European Journal of Endocrinology;1999-12-01

5. Effects of lanreotide, a somatostatin analogue, on postprandial gastric functions and biliopancreatic secretions in humans;British Journal of Clinical Pharmacology;1997-01